Lista de obras - Kholoud Porter - Dominio Público Uruguay

2010 Guidelines for Antiretroviral Treatment of HIV From the International AIDS Society–USA Panel

artículo científico publicado en 2010

A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.

artículo científico publicado en 2017

A global survey of HIV-positive people's attitudes towards cure research.

artículo científico publicado en 2016

A systematic review of definitions of extreme phenotypes of HIV control and progression

artículo científico publicado en 2014

AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change

article

An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries ⬇️

artículo científico publicado el 13 de noviembre de 2010

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration

artículo científico publicado en 2014

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease

artículo científico publicado en 2011

Antiretroviral treatment of primary HIV infection to reduce onward transmission

artículo científico publicado en 2010

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

artículo científico publicado en 2008

Authors' response to Drs Scourfield, Jackson and Nelson

artículo científico publicado en 2011

Beyond viral suppression of HIV - the new quality of life frontier

artículo científico publicado en 2016

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

artículo científico publicado en 2016

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

artículo científico publicado en 2017

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003

scientific article published on 01 April 2007

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

article

CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.

scientific article published on 31 March 2009

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.

artículo científico

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

artículo científico

Changes in the risk of death after HIV seroconversion compared with mortality in the general population

artículo científico publicado en 2008

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

artículo científico publicado en 2002

Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study

artículo científico

Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions

artículo científico publicado en 2017

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

artículo científico publicado en 2017

Constructing the cascade of HIV care: methods for measurement.

artículo científico publicado en 2015

Current CD4 Cell Count and the Short‐Term Risk of AIDS and Death before the Availability of Effective Antiretroviral Therapy in HIV‐Infected Children and Adults

article

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

artículo científico publicado en 2010

Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals

artículo científico publicado en 2011

Detection of drug resistance associated mutations in HIV primary infection within the UK.

artículo científico publicado en 2000

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion

article

Development and future directions for the Joint United Nations Programme on HIV/AIDS estimates

artículo científico publicado en 2014

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates

article

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa

artículo científico publicado en 2012

Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study

artículo científico publicado en 2009

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters

article

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

artículo científico publicado en 2015

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

artículo científico publicado en 2013

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.

artículo científico publicado en 2012

Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older

artículo científico publicado en 2017

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

artículo científico publicado en 2011

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

artículo científico publicado en 2006

European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements

artículo científico publicado en 2015

Evaluating the effect of year of seroconversion on HIV progression in cohort studies. Italian Seroconversion Study.

artículo científico

Evaluating the impact of functional genetic variation on HIV-1 control

artículo científico publicado en 2017

Evaluation of rapid progressors in HIV infection as an extreme phenotype

artículo científico publicado en 2014

From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa

artículo científico

Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in Women

article

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.

artículo científico publicado en 2016

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

artículo científico publicado en 2015

HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay

artículo científico publicado en 2017

HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression

artículo científico publicado en 2014

Harness suspension and first aid management: development of an evidence-based guideline.

artículo científico publicado en 2010

High percentage of recent HIV infection leading to onward transmission in Odessa, Ukraine associated with young adults

artículo científico publicado en 2014

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.

artículo científico publicado en 2006

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

artículo científico publicado en 2011

Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion—Reply

article

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.

artículo científico publicado en 2012

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

artículo científico publicado en 2011

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

artículo científico publicado en 2014

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection

artículo científico publicado en 2012

Increasing incidence of cryptococcosis in the United Kingdom

artículo científico publicado en 1993

Indirect methods for estimating prevalent HIV infections: adults in England and Wales at the end of 1993

article

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression

artículo científico publicado en 2014

Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study

artículo científico publicado en 2009

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion

artículo científico publicado en 2010

Late presenters in an HIV surveillance system in Italy during the period 1992-2006.

artículo científico publicado en 2008

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.

artículo científico publicado en 2016

Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.

artículo científico publicado en 2014

Men and the young are key to reaching the first 90.

artículo científico publicado en 2017

Molecular epidemiology of recent HIV-1 infections in southern Poland

article

Natural history of HIV-control since seroconversion

artículo científico publicado en 2013

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

artículo científico publicado en 2009

Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions

artículo científico publicado en 2009

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

artículo científico publicado en 2012

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection

artículo científico publicado en 2017

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies

artículo científico publicado en 2010

Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

artículo científico publicado en 2005

Primary HIV infection: to treat or not to treat?

scientific article published on February 2008

Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data

artículo científico publicado en 2005

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

article

Rate of CD4 Decline and HIV-RNA Change Following HIV Seroconversion in Men Who Have Sex With Men

article

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice

artículo científico publicado en 2008

Relating HIV testing patterns in Poland to risky and protective behaviour.

artículo científico publicado en 2015

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters

artículo científico publicado en 2010

Risk of tuberculosis following HIV seroconversion in high-income countries

artículo científico publicado en 2012

Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure

artículo científico publicado en 2013

Routine surveillance data on AIDS and HIV infections in the UK: a description of the data available and their use for short-term planning

artículo científico publicado en 1988

Short-Course Antiretroviral Therapy in Primary HIV Infection

article

Short-Term CD4 Cell Response After Highly Active Antiretroviral Therapy Initiated at Different Times From Seroconversion in 1500 Seroconverters

article

Short-course antiretroviral therapy in primary HIV infection

artículo científico publicado en 2013

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort

article

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection

artículo científico publicado en 2013

Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion

article

Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002.

artículo científico publicado en 2007

Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study

artículo científico publicado en 2014

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort

artículo científico publicado en 2017

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges

artículo científico publicado en 2017

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK

artículo científico publicado en 2015

The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy

artículo científico publicado en 2008

The effect of antiretroviral treatment of different durations in primary HIV infection

artículo científico publicado en 2008

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

artículo científico publicado en 2015

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.

artículo científico

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

artículo científico publicado en 2015

The practical significance of potential biases in estimates of the AIDS incubation period distribution _in the UK Register of HIV Seroconverters

artículo científico publicado en 1999

The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes

artículo científico

The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study

artículo científico publicado en 2005

The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort.

artículo científico publicado en 2003

Towards standardized definitions for monitoring the continuum of HIV care in Europe

artículo científico publicado en 2017

Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study

article

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations

artículo científico

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

artículo científico publicado en 2011

Using incidence assays within the context of the recent infections testing algorithm

artículo científico publicado en 2014

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe

artículo científico publicado en 2017

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration

artículo científico publicado en 2013

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection.

artículo científico publicado en 2016

Lista de obras de Kholoud Porter

2010 Guidelines for Antiretroviral Treatment of HIV From the International AIDS Society–USA Panel

A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.

A global survey of HIV-positive people's attitudes towards cure research.

A systematic review of definitions of extreme phenotypes of HIV control and progression

AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change

An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries ⬇️

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease

Antiretroviral treatment of primary HIV infection to reduce onward transmission

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

Authors' response to Drs Scourfield, Jackson and Nelson

Beyond viral suppression of HIV - the new quality of life frontier

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

Changes in the risk of death after HIV seroconversion compared with mortality in the general population

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study

Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

Constructing the cascade of HIV care: methods for measurement.

Current CD4 Cell Count and the Short‐Term Risk of AIDS and Death before the Availability of Effective Antiretroviral Therapy in HIV‐Infected Children and Adults

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals

Detection of drug resistance associated mutations in HIV primary infection within the UK.

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion

Development and future directions for the Joint United Nations Programme on HIV/AIDS estimates

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa

Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.

Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion

European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements

Evaluating the effect of year of seroconversion on HIV progression in cohort studies. Italian Seroconversion Study.

Evaluating the impact of functional genetic variation on HIV-1 control

Evaluation of rapid progressors in HIV infection as an extreme phenotype

From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa

Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in Women

HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014

HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay

HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression

Harness suspension and first aid management: development of an evidence-based guideline.

High percentage of recent HIV infection leading to onward transmission in Odessa, Ukraine associated with young adults

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion—Reply

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection

Increasing incidence of cryptococcosis in the United Kingdom

Indirect methods for estimating prevalent HIV infections: adults in England and Wales at the end of 1993

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression

Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study

Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion

Late presenters in an HIV surveillance system in Italy during the period 1992-2006.

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.

Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.

Men and the young are key to reaching the first 90.

Molecular epidemiology of recent HIV-1 infections in southern Poland

Natural history of HIV-control since seroconversion

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies

Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

Primary HIV infection: to treat or not to treat?

Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data